Tel. +49 203 / 555858-31,-32,-33 · Fax: +49 203 / 35 82 99
21.01.2020
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
21.01.2020
3D Genomemedicine Inc is going to operate in USA
Genekam is to take part in European Community FP7 funded and approved research project called STRUCTGEL to develop nanomedicine applications in Stemcell field.